Laboratories
Home > Laboratories > Yokohama Institute > Center for Genomic Medicine > Research Group for Disease-causing Mechanism > Laboratory for Autoimmune Diseases
Laboratory for Autoimmune Diseases
Kazuhiko YAMAMOTO
Laboratory Head
Kazuhiko YAMAMOTO (M.D., Ph.D.)
mail

Research Areas

Autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are considered to be complex multi-genetic diseases. Our goal is to identify disease susceptibility genes for RA and SLE by genome-wide association studies in Japanese population using single nucleotide polymorphisms. as well as methods of molecular genetics and immunology. We have reported multiple RA-associated genes including four major findings on "PADI4", "SLC22A4", "FCRL3", "CD244"and "CCR6). We also study how these genes are involved in the disease pathogenesis by usign animal disease models.

Research Subject

  1. Genome-wide association study for rheumatoid arthritis
  2. Genome-wide association study for systemic lupus erythematosus
  3. Functional analysis of rheumatoid arthritis-associated genes, PADI4, SLC22A4, FCRL3, and CD244
  4. Discovery of novel rheumatoid arthritis-associated gene(s) in HLA region with linkage disequilibrium analysis

Related links

  1. RIKEN Center for Genomic Medicine Website_Laboratories PageNew Window

Press release

May 10,2010
CCR6 gene identified as causative factor in onset of articular rheumatism
September 15, 2008
Identifying a new gene, CD244, causing rheumatoid arthritis

RIKEN RESEARCH

July 09,2010
Inviting arthritic trouble
A large-scale genetic screen reveals a factor that makes rheumatoid arthritis patients' joints vulnerable to immune attackNew Window
January 09, 2009
Double trouble
Variations in a single gene simultaneously increase the risk of two autoimmune conditionsNew Window

List of Selected Publications

  1. Kochi, Y, Okada, Y, Suzuki, A, et al:
    "A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility"
    Nature Genetics, 42 (6): 515-9 (2010)
  2. Okada, Y, Yamada, R, Yamamoto, K., et al:
    "Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1"
    Arthritis & Rheumatism 60(12):3582-90 (2009).
  3. Kochi, Y., Myouzen, K., Yamamoto, K., et al:
    "FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling"
    Journal of Immunology 183(9):5502-10 (2009)
  4. Shimane, K, Kochi, Y, Yamamoto, K., et al:
    "A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population."
    Annals of Rheumatic Diseases., 68(3), 377-383 (2009)
  5. Suzuki, A, Yamada, R, Yamamoto, K., et al:
    "Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population."
    Nature Genetics, 40(10), 1224-1229 (2008).
  6. Okazaki, Y, Suzuki, A, Yamamoto, K., et al:
    "Identification of citrullinated eukaryotic translation initiation factor 4G1 as novel autoantigen in rheumatoid arthritis"
    Biochemical and Biophysical Research Communications, 341, 94-100 (2006).
  7. Suzuki, A, Yamada, R, Yamamoto, K., et al:
    "Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis"
    Biochemical and Biophysical Research Communications, 333, 418-426 (2005).
  8. Kochi, Y., Yamada, R., Yamamoto, K., et al:
    "Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences"
    Arthritis & Rheumatism 50(1), 63-71 (2004).
  9. Tokuhiro, S., Yamada, S., Yamamoto, K., et al:
    "An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis"
    Nature Genetics, 35(4), 341-348 (2003).
  10. Suzuki, A., Yamada, R., Yamamoto, K., et al:
    "Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis"
    Nature Genetics, 34(4), 395-402 (2003).